The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
 
Karyn A. Goodman
Consulting or Advisory Role - Pfizer
 
Donna Niedzwiecki
No Relationships to Disclose
 
Nathan Hall
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; Merrimack; NCCN; Pfizer; Research to Practice; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Merck; Polaris
 
Xing Ye
No Relationships to Disclose
 
Michael O. Meyers
No Relationships to Disclose
 
Kisha Mitchell-Richards
No Relationships to Disclose
 
Daniel J Boffa
No Relationships to Disclose
 
Wendy L Frankel
No Relationships to Disclose
 
Alan P. Venook
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Merck Serono; Roche
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
 
Christopher H. Crane
Honoraria - EMD Serono; Vertex
Consulting or Advisory Role - EMD Serono; vertex
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Gilead Sciences; Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Merrimack; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst); Polaris (Inst); Sanofi (Inst)
 
David H. Ilson
Consulting or Advisory Role - Amgen; Lilly/ImClone; Roche/Genentech
Speakers' Bureau - Genentech/Roche
Travel, Accommodations, Expenses - Amgen; Genentech/Roche